Vertebral Fracture clinical trials

Explore recruiting vertebral fracture clinical trials.

Recruiting vertebral fracture studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vertebral Fracture trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Preventive effect of 5% lidocaine patch on the development of neuropathic pain following an osteoporotic vertebral fracture: A proof-of-concept, controlled, randomized trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective, randomized, multicentre study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures in women with a clinical vertebral fracture or recent hip fracture (imminent risk of fracture) caused by bone fragility.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Strategies for zoledronic acid post-denosumab discontinuation in postmenopausal osteoporosis

France

Therapeutic use (Phase IV) EU CTIS Study details

Treatment with zoledronate subsequent to denosumab in osteoporosis 2

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase II Multicenter, Open-Label Study to evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Pediatric Patients with Duchenne Muscular Dystrophy (SHIELD DMD)

Poland, Spain, Italy, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of adynamic bone disorder with parathyroid hormone in patients with chronic kidney disease

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Vertebral Fracture trials by city

Vertebral Fracture in Toronto Vertebral Fracture in Vancouver Vertebral Fracture in Montreal Vertebral Fracture in Calgary Vertebral Fracture in Edmonton Vertebral Fracture in Ottawa Vertebral Fracture in Winnipeg Vertebral Fracture in Quebec City Vertebral Fracture in Hamilton Vertebral Fracture in Kitchener Vertebral Fracture in London Vertebral Fracture in Halifax Vertebral Fracture in New York Vertebral Fracture in Los Angeles Vertebral Fracture in Chicago Vertebral Fracture in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease